TSS
BIVIW

Two Sigma Securities’s BioVie Inc Warrant BIVIW Stock Holding History

Two Sigma Securities’s Portfolio BIVIW Stock Details BIVIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.45K Sell
11,134
-2,904
-21% -$835 ﹤0.01% 1538
2025
Q4 		$3.8K Buy
14,038
+328
+2% +$107 ﹤0.01% 1354
2025
Q3 		$5.65K Buy
+13,710
New +$5.58K ﹤0.01% 1249

Other funds holding BIVIW

DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return

Two Sigma Securities's BIVIW Position: Q1 2026 in Review

Two Sigma Securities reduced its BioVie Inc Warrant (BIVIW) stake by 21% in Q1 2026, selling an estimated $835 and leaving 11,134 shares worth $3.45K. The position accounts for ﹤0.01% of the portfolio, ranked #1538.

Two Sigma Securities first reported a position in BIVIW in Q3 2025 and has held it in 3 quarters since. The position peaked at $5.65K in Q3 2025. 8 funds tracked by Wall St. Rank hold BIVIW as of Q1 2026.

  • Two Sigma Securities held 11,134 shares of BioVie Inc Warrant worth $3.45K as of Q1 2026.
  • Two Sigma Securities sold 2,904 BioVie Inc Warrant shares in Q1 2026, an estimated $835.
  • BioVie Inc Warrant made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1538 holding.
  • Two Sigma Securities first reported a position in BioVie Inc Warrant in Q3 2025 and has held it in 3 quarters since.
  • Two Sigma Securities's BioVie Inc Warrant position peaked at $5.65K in Q3 2025.
  • 8 funds tracked by Wall St. Rank held BioVie Inc Warrant as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.